Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 174

1.

Impact of Previous Exposure to Macrolide Antibiotics on Helicobacter pylori Infection Treatment Outcomes.

Boltin D, Levi Z, Gingold-Belfer R, Gabay H, Shochat T, Niv Y, Dickman R, Dotan I, Birkenfeld S.

Am J Gastroenterol. 2019 Apr 25. doi: 10.14309/ajg.0000000000000223. [Epub ahead of print]

PMID:
31095531
2.

Assessment of small bowel mucosal healing by video capsule endoscopy for the prediction of short-term and long-term risk of Crohn's disease flare: a prospective cohort study.

Ben-Horin S, Lahat A, Amitai MM, Klang E, Yablecovitch D, Neuman S, Levhar N, Selinger L, Rozendorn N, Turner D, Chowers Y, Odes S, Schwartz D, Yanai H, Dotan I, Braun T, Haberman Y, Kopylov U, Eliakim R; Israeli IBD Research Nucleus (IIRN).

Lancet Gastroenterol Hepatol. 2019 May 9. pii: S2468-1253(19)30088-3. doi: 10.1016/S2468-1253(19)30088-3. [Epub ahead of print]

PMID:
31080097
3.

Fecal Proteases from Pouchitis Patients Activate Protease Activating Receptor-2 to Disrupt the Epithelial Barrier.

Hoffman S, Cohen NA, Carroll IM, Tulchinsky H, Borovok I, Dotan I, Maharshak N.

J Crohns Colitis. 2019 May 6. pii: jjz086. doi: 10.1093/ecco-jcc/jjz086. [Epub ahead of print]

PMID:
31056700
4.

Clock Gene Disruption is an Initial Manifestation of Inflammatory Bowel Disease.

Weintraub Y, Cohen S, Chapnik N, Ben-Tov A, Yerushalmy-Feler A, Dotan I, Tauman R, Froy O.

Clin Gastroenterol Hepatol. 2019 Apr 10. pii: S1542-3565(19)30373-8. doi: 10.1016/j.cgh.2019.04.013. [Epub ahead of print]

PMID:
30981000
5.

Glycemic variability and mortality in patients hospitalized in general surgery wards.

Akirov A, Shochat T, Dotan I, Diker-Cohen T, Gorshtein A, Shimon I.

Surgery. 2019 Apr 9. pii: S0039-6060(19)30114-X. doi: 10.1016/j.surg.2019.02.022. [Epub ahead of print]

PMID:
30979427
6.

Fruit consumption is associated with alterations in microbial composition and lower rates of pouchitis.

Godny L, Maharshak N, Reshef L, Goren I, Yahav L, Fliss-Isakov N, Gophna U, Tulchinsky H, Dotan I.

J Crohns Colitis. 2019 Mar 4. pii: jjz053. doi: 10.1093/ecco-jcc/jjz053. [Epub ahead of print]

PMID:
30828722
7.

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus.

Danese S, Allez M, van Bodegraven AA, Dotan I, Gisbert JP, Hart A, Lakatos PL, Magro F, Peyrin-Biroulet L, Schreiber S, Tarabar D, Vavricka S, Halfvarson J, Vermeire S.

Dig Dis. 2019;37(4):266-283. doi: 10.1159/000496739. Epub 2019 Feb 6.

8.

Gut microbiota density influences host physiology and is shaped by host and microbial factors.

Contijoch EJ, Britton GJ, Yang C, Mogno I, Li Z, Ng R, Llewellyn SR, Hira S, Johnson C, Rabinowitz KM, Barkan R, Dotan I, Hirten RP, Fu SC, Luo Y, Yang N, Luong T, Labrias PR, Lira S, Peter I, Grinspan A, Clemente JC, Kosoy R, Kim-Schulze S, Qin X, Castillo A, Hurley A, Atreja A, Rogers J, Fasihuddin F, Saliaj M, Nolan A, Reyes-Mercedes P, Rodriguez C, Aly S, Santa-Cruz K, Peters L, Suárez-Fariñas M, Huang R, Hao K, Zhu J, Zhang B, Losic B, Irizar H, Song WM, Di Narzo A, Wang W, Cohen BL, DiMaio C, Greenwald D, Itzkowitz S, Lucas A, Marion J, Maser E, Ungaro R, Naymagon S, Novak J, Shah B, Ullman T, Rubin P, George J, Legnani P, Telesco SE, Friedman JR, Brodmerkel C, Plevy S, Cho JH, Colombel JF, Schadt EE, Argmann C, Dubinsky M, Kasarskis A, Sands B, Faith JJ.

Elife. 2019 Jan 22;8. pii: e40553. doi: 10.7554/eLife.40553.

9.

Improvement in the implementation of Helicobacter pylori management guidelines among primary care physicians following a targeted educational intervention.

Boltin D, Dotan I, Birkenfeld S.

Ann Gastroenterol. 2019 Jan-Feb;32(1):52-59. doi: 10.20524/aog.2018.0329. Epub 2018 Nov 24.

10.

Correlation between Quantitative 13C-Urea Breath Test and Helicobacter pylori Treatment Success in a Population-Based Cohort.

Boltin D, Levi Z, Perets TT, Schmilovitz-Weiss H, Gingold-Belfer R, Dickman R, Dotan I.

Gastroenterol Res Pract. 2018 Nov 13;2018:5439539. doi: 10.1155/2018/5439539. eCollection 2018.

11.

Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch.

Goren I, Godny L, Reshef L, Yanai H, Gophna U, Tulchinsky H, Dotan I.

Inflamm Bowel Dis. 2019 Mar 14;25(4):742-749. doi: 10.1093/ibd/izy370.

PMID:
30535148
12.
13.

Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach.

Danese S, Banerjee R, Cummings JF, Dotan I, Kotze PG, Leong RWL, Paridaens K, Peyrin-Biroulet L, Scott G, Assche GV, Wehkamp J, Yamamoto-Furusho JK.

Intest Res. 2018 Oct;16(4):522-528. doi: 10.5217/ir.2018.00073. Epub 2018 Oct 16.

14.

The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.

Bar Yehuda S, Axlerod R, Toker O, Zigman N, Goren I, Mourad V, Lederman N, Cohen N, Matz E, Dushnitzky D, Gavish M, Borovsky N, Schwarts D, Dotan I, Turner D.

J Crohns Colitis. 2019 Mar 26;13(3):324-329. doi: 10.1093/ecco-jcc/jjy166.

PMID:
30304371
15.

Genotype-Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases.

Ben-Shachar S, Finezilber Y, Elad H, Rabinowitz K, Goren I, Isakov O, Yanai H, Dotan I.

Inflamm Bowel Dis. 2019 Jan 10;25(2):336-344. doi: 10.1093/ibd/izy231.

PMID:
30265311
16.

Endoscopic findings and esophageal cancer incidence among Fanconi Anemia patients participating in an endoscopic surveillance program.

Itskoviz D, Tamary H, Krasnov T, Yacobovich J, Sahar N, Zevit N, Shamir R, Ben-Bassat O, Leibovici Wiseman Y, Dickman R, Ringel Y, Dotan I, Goldberg Y, Morgenstern S, Levi Z.

Dig Liver Dis. 2019 Feb;51(2):242-246. doi: 10.1016/j.dld.2018.08.010. Epub 2018 Aug 18.

PMID:
30249500
17.

Optimization of 13 C-urea breath test threshold levels for the detection of Helicobacter pylori infection in a national referral laboratory.

Perets TT, Gingold-Belfer R, Leibovitzh H, Itskoviz D, Schmilovitz-Weiss H, Snir Y, Dickman R, Dotan I, Levi Z, Boltin D.

J Clin Lab Anal. 2019 Feb;33(2):e22674. doi: 10.1002/jcla.22674. Epub 2018 Sep 17.

PMID:
30221401
18.

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience.

Kopylov U, Avni-Biron I, Ron Y, Koslowsky B, Waterman M, Daher S, Ungar B, Schwartz D, Zittan E, Openhaim M, Yanai H, Maharshak N, Bar Gil Shitrit A, Naftali T, Eliakim R, Chowers Y, Ben-Horin S, Dotan I.

Dig Liver Dis. 2019 Jan;51(1):68-74. doi: 10.1016/j.dld.2018.07.040. Epub 2018 Aug 10.

PMID:
30172649
19.

Video capsule endoscopy is safe and effective in suspected small bowel bleeding among left ventricular assist device recipients.

Itskoviz D, Ben Avraham B, Banai H, Avni I, Ben Gal T, Dotan I, Gal E.

Int J Artif Organs. 2018 Dec;41(12):833-837. doi: 10.1177/0391398818790205. Epub 2018 Aug 3.

PMID:
30073890
20.

Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?

Aloush V, Dotan I, Ablin JN, Elkayam O.

Clin Exp Rheumatol. 2019 Jan-Feb;37(1):32-36. Epub 2018 Jun 25.

PMID:
29998822

Supplemental Content

Loading ...
Support Center